Pulmonx Corporation (LUNG) Tops Q4 EPS by 4c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Pulmonx Corp. (LUNG) PT Raised to $12 at Citi, Downgraded From Buy-High Risk to Buy
February 23, 2023 5:50 AM ESTCiti analyst Joanne Wuensch raised the price target on Pulmonx Corp. (NASDAQ: LUNG) to $12.00 (from $10.00) while maintaining a Buy rating.
The analyst comments "Pulmonxs 4Q22 sales were better than expected, delivering $15.4M (up 18.4% y/y ex-fx), ahead of consensuss... More
